Molecule Name |
DB00251
|
DrugBank Groups |
Approved
|
Cluster No |
111
|
Smiles |
ClC1(=C(C=CC(=C1)Cl)C4(OC(COC3(=CC=C(N2(CCN(C(C)C)CC2))C=C3))CO4)(CN5(N=CN=C5)))
|
Download |
mol2, pdbqt
|
TPSA |
64,88
|
Non-H Atoms |
36
|
Non-C/H Atoms |
10
|
Metal-Atoms |
0
|
Electronegative Atoms |
10
|
Stereo Centers |
2
|
Rotatable Bonds |
8
|
Rings Closures |
5
|
Small Rings |
5
|
Aromatic Rings |
3
|
Aromatic Atoms |
17
|
sp3-Atoms |
16
|
Symmetric atoms |
5
|
cLogS |
-4,057
|
MW |
532,47
|
cLogP |
3,7184
|
HBA |
8
|
HBD |
0
|
Ro5 violations |
1
|
Druglikeness |
6,6933
|
DrugScore |
0,537632237373085
|
Mutagenic |
none
|
Tumorigenic |
none
|
Reproductive Effective |
none
|
Irritant |
none
|
Blood-Brain Barrier |
BBB+
|
Human Intestinal Absorption |
HIA+
|
Caco-2 Permeability |
Caco2+
|
P-glycoprotein Substrate |
Substrate
|
P-glycoprotein Inhibitor |
Inhibitor
|
P-glycoprotein Inhibitor 2 |
Inhibitor
|
Renal Organic Cation Transporter |
Inhibitor
|
Aqueous solubility |
-3,6283
|
Caco-2 Permeability 2 |
1,2348
|
Subcellular localization |
Mitochondria
|
CYP450 2C9 Substrate |
Non-substrate
|
CYP450 2D6 Substrate |
Non-substrate
|
CYP450 3A4 Substrate |
Substrate
|
CYP450 1A2 Inhibitor |
Non-inhibitor
|
CYP450 2C9 Inhibitor |
Non-inhibitor
|
CYP450 2D6 Inhibitor |
Non-inhibitor
|
CYP450 2C19 Inhibitor |
Non-inhibitor
|
CYP450 3A4 Inhibitor |
Inhibitor
|
CYP Inhibitory Promiscuity |
High CYP Inhibitory Promiscuity
|
Human Ether-a-go-go-Related Gene Inhibition |
Weak inhibitor
|
Human Ether-a-go-go-Related Gene Inhibition 2 |
Inhibitor
|
AMES Toxicity |
Non AMES toxic
|
Carcinogens |
Non-carcinogens
|
Fish Toxicity |
High FHMT
|
Fish Toxicity (pLC50, mg/L) |
1,0346
|
Tetrahymena Pyriformis Toxicity |
High TPT
|
Tetrahymena Pyriformis Toxicity (pIGC50, ug/L) |
0,7204
|
Honey Bee Toxicity |
Low HBT
|
Biodegradation |
Not ready biodegradable
|
Acute Oral Toxicity |
III
|
Rat Acute Toxicity (LD50, mol/kg) |
2,8114
|
Carcinogenicity (Three-class) |
Non-required
|